The Company has commitments with two other pharmaceutical contract manufacturers and suppliers, including certain future purchase obligations of approximately $ 1.7 million
ALX Oncology Holdings Inc. Customers
No clients on recordNo downstream customers found in our database for ALX Oncology Holdings Inc..
ALX Oncology Holdings Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
ALXO-DEBT
Debt stack $14.8M
90%
Market cache reports total debt of $14.8M.
ALXO-DEBT-7707
Warrants outstanding: 61292
90%
xbrl warrant detail from xbrl 2026-03-31.
ALXO-DEBT-7708
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2020-12-31.
ALX Oncology Holdings Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for ALX Oncology Holdings Inc..
ALX Oncology Holdings Inc. Ownership
Holder
Name
Confidence
Evidence
ALXO-OWNER-RA-CAPITAL-MANAGEMENT-L-P
RA CAPITAL MANAGEMENT, L.P.
90%
13F overlay lists RA CAPITAL MANAGEMENT, L.P. as top holder; 72 tracked holders.
ALX Oncology Holdings Inc. Extended Supply Chain Network